BDBM322976 5-tert-butyl-3-[(2-chlorophenyl)methyl]-7-(5-methylpyridin-2-yl)triazolo[4,5-d]pyrimidine::US10183946, Example 7

SMILES Cc1ccc(nc1)-c1nc(nc2n(Cc3ccccc3Cl)nnc12)C(C)(C)C

InChI Key InChIKey=FJXFFRLWPBLZQE-UHFFFAOYSA-N

Data  2 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 322976   

TargetCannabinoid receptor 2(Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM322976(5-tert-butyl-3-[(2-chlorophenyl)methyl]-7-(5-methy...)
Affinity DataEC50:  488nMAssay Description:CHO cells expressing human CB1 or CB2 receptors are seeded 17-24 hours prior to the experiment 50.000 cells per well in a black 96 well plate with fl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2019
Entry Details
US Patent

TargetCannabinoid receptor 1(Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM322976(5-tert-butyl-3-[(2-chlorophenyl)methyl]-7-(5-methy...)
Affinity DataEC50: >1.00E+4nMAssay Description:CHO cells expressing human CB1 or CB2 receptors are seeded 17-24 hours prior to the experiment 50.000 cells per well in a black 96 well plate with fl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2019
Entry Details
US Patent